Sufentanil citrate
Drug ingredientActive ShortageCAS 60561-17-3
This drug ingredient is in active FDA shortage. At least one manufacturer cannot meet demand.
This chemical is not on EPA’s Toxic Substances Control Act inventory, the list behind EPA’s production survey.
Why supply is unknownProduction is reported production, not a complete census of factories. Import value and source-country shares describe a shared customs category, not a separate chemical measurement.
Where It Comes From
Customs basis: HS 293491 · basket
These shares come from HS customs code 293491, which covers 3 tracked chemicals in total. They estimate the category's origin mix, not this chemical specifically.
- Slovakia
- Malaysia
7 FDA-registered drug labelers
Why It Matters
Appears in 1 drug and cosmetic product listings (FDA).
- •Sufentanil Citrate
- Current shortage
Sufentanil Citrate Injection
Shortage listed since May 3, 2022
Manufacturer reports: 1 unavailable, 1 available
Chemical Identity
Data Sources
- PubChem · compound 65494Retrieved 2026-04-07
- FDA National Drug Code directoryRetrieved 2026-04-25
- FDA Drug ShortagesRetrieved 2026-10-04
- US Census international tradeReporting year: 2024 · Retrieved 2026-10-04
Brief citations
Sufentanil citrate (CAS 60561-17-3) https://chemicalindependence.com/chemical/60561-17-3/ PubChem: 65494. Retrieved 2026-04-07. https://pubchem.ncbi.nlm.nih.gov/compound/65494 FDA National Drug Code directory: CAS 60561-17-3. Retrieved 2026-04-25. https://open.fda.gov/data/ndc/ FDA Drug Shortages: CAS 60561-17-3. Retrieved 2026-10-04. https://www.accessdata.fda.gov/scripts/drugshortages/ US Census international trade: HS 293491 for CAS 60561-17-3. Reporting year: 2024. https://usatrade.census.gov/